NewswireToday - /newswire/ -
Shirley, NY, United States, 2015/05/27 - Creative Bioarray, an international supplier of the world's most comprehensive list of research-use cells, including stem cells, tumor cells, primary cells, & transformed cells is pleased to announce an new primary cells product - Human Cardiomyocytes.
Creative Bioarray, an international supplier of the world's most comprehensive list of research-use cells, including stem cells, tumor cells, primary cells, and transformed cells, is pleased to announce an new primary cells product---Human Cardiomyocytes (Cat.No. CSC-C2847) to its cells catalog being offered to research community.
This new product-Cardiomyocytes are derived from the whole heart (of a single donor) which has been dissociated into single cells and cultured using differential adhesion. Moreover, these cells are characterized by immunostaining of cardiac sarcomeric actin, myosin heavy chain and other cardiac markers.
It may be used in various in vitro or in vivo studies; transplantation into normal or diseased systems; cardiac toxicology studies; or cardiovascular developmental studies.
We’re glad to offer our help to cells researchers, and that’s what we’ve done since our foundation. said Dr. Hannah Cole, the senior scientific officer of R&D department of Creative Bioarray.
About Creative Bioarray
Found in 2004, Creative Bioarray (creative-bioarray.com) is an innovative biotechnology company whose mission is to develop unique technologies that provide researchers with the tools to investigate life science. Creative Bioarray provides a wide range of high quality normal human and animal cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services for the research community. Their products are currently used around the world in the biological laboratories of universities, government institutes, biotechnology and pharmaceutical companies.
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
F: 631-614-7828 - E: info[.]creative-bioarray.com.